Clinical Trials

Title   A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination with Estradiol/Norethinedrone Acetate in Subjects with Moderate to Severe Endometriosis-Associated Pain
Description   A randomized study evaluating the continued safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult pre-menopausal female subjects.
IRB Number   927324-1
Status   Active
Start Date   09/12/2017
Principal Name   Botros Rizk, MD
Contact Name   Casey Armistead

Email Newsletters

Connect With Us